Rupali Doshi
Impact in
- Infectious Diseases top 10%
- HIV/AIDS Research and Interventions
- Virology top 10%
- HIV Research and Treatment
Papers in
-
- HIV/AIDS Research and Interventions 15
- HIV/AIDS drug development and treatment 2
- Epidemiology 14
- HIV, Drug Use, Sexual Risk 12
- Co-authors
- John Milberg (2 shared papers)Laura W. Cheever (2 shared papers)Deborah Isenberg (1 shared paper)Faye Malitz (1 shared paper)Thomas R. Matthews (1 shared paper)Louis DeSantis (2 shared papers)David J. Malebranche (1 shared paper)B. Scatton (1 shared paper)
- Journals
- JMIR Public Health and Surveillance (2 papers)AIDS and Behavior (2 papers)AIDS Research and Human Retroviruses (2 papers)Journal of Community Health (2 papers)Clinical Infectious Diseases (1 paper)
- Partner nations
- United StatesIndiaCanada
In The Last Decade
Rupali Doshi
19 papers receiving 315 citations
Peers
Comparison fields: 5 of 65
- Infectious Diseases 209
- Virology 41
- Applied Microbiology and Biotechnology 10
- Epidemiology 168
- General Health Professions 99
Countries citing papers authored by Rupali Doshi
This map shows the geographic impact of Rupali Doshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rupali Doshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rupali Doshi more than expected).
Fields of papers citing papers by Rupali Doshi
This network shows the impact of papers produced by Rupali Doshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rupali Doshi. The network helps show where Rupali Doshi may publish in the future.
Co-authors
The 25 scholars most cited alongside Rupali Doshi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 89 | |
| 2 | Neuroprotective effects of eliprodil in retinal excitotoxicity and ischemia. | 1999 | 43 |
| 3 | 2017 | 39 | |
| 4 | 2012 | 37 | |
| 5 | 2009 | 29 | |
| 6 | 2020 | 13 | |
| 7 | 2019 | 12 | |
| 8 | 2012 | 11 | |
| 9 | 2020 | 9 | |
| 10 | 2021 | 9 | |
| 11 | 2019 | 6 | |
| 12 | 2018 | 6 | |
| 13 | 2010 | 5 | |
| 14 | 2019 | 3 | |
| 15 | In vitro and in vivo protective effects of eliprodil in the retina | 1997 | 2 |
| 16 | 2023 | 2 | |
| 17 | 2023 | 1 | |
| 18 | 2025 | 1 | |
| 19 | 2001 | 1 | |
| 20 | 2025 | 0 |
About Rupali Doshi
Rupali Doshi is a scholar working on Infectious Diseases, Epidemiology, General Health Professions, Virology and Sociology and Political Science, having authored 24 papers that have together received 318 indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (15 papers), HIV, Drug Use, Sexual Risk (12 papers), HIV Research and Treatment (4 papers), Sex work and related issues (4 papers), Adolescent Sexual and Reproductive Health (2 papers), Drug-Induced Ocular Toxicity (2 papers), HIV/AIDS drug development and treatment (2 papers) and Homelessness and Social Issues (2 papers). The work is most often cited by research in Infectious Diseases (209 citations), Virology (41 citations), Applied Microbiology and Biotechnology (10 citations), Epidemiology (168 citations) and General Health Professions (99 citations). Rupali Doshi has collaborated with scholars based in United States, India and Canada. Frequent co-authors include John Milberg, Laura W. Cheever, Deborah Isenberg, Faye Malitz, Thomas R. Matthews, Louis DeSantis, David J. Malebranche, B. Scatton, Michael L. Chandler and Lisa Bowleg. Their work appears in journals such as JMIR Public Health and Surveillance, AIDS and Behavior, AIDS Research and Human Retroviruses, Journal of Community Health and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.